Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 31 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 10 | 326−4.7%/yr | −4.7%/yr | 3.41.3× | 0% | 340 in 2030+0.7%/yr |
| Lumbar fusion | 8 | 294−2.1%/yr | −2.1%/yr | 3.11.5× | 0% | 460 in 2030+7.8%/yr |
| Cervical fusion & disc arthroplasty | 0 | 112−1%/yr | −1%/yr | 1.21.1× | 0% | 210 in 2030+11%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 58 | 12,053+0.5%/yr | +0.5%/yr | 125.01.4× | 32% | 14,900 in 2030+3.6%/yr |
| Skin substitutes & wound grafts | 3 | 886−5.4%/yr | −5.4%/yr | 5.21.0× | 41% | 870 in 2030−0.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 12 | 502+15%/yr | +15%/yr | 5.20.7× | 75% | 740 in 2030+6.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Dialysis access | 3 | 655−9.9%/yr | −9.9%/yr | 7.51.4× | 100% | 610 in 2030−1.3%/yr |
| Peripheral arterial intervention | 4 | 346−12%/yr | −12%/yr | 3.60.7× | 54% | 380 in 2030+1.5%/yr |
| Superficial venous ablation | 5 | 302−2.7%/yr | −2.7%/yr | 3.10.9× | 100% | 410 in 2030+5.3%/yr |
| Carotid revascularization | 3 | 142+2.9%/yr | +2.9%/yr | 1.51.5× | 0% | 70 in 2030−11%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 6 | 457−5.4%/yr | −5.4%/yr | 5.40.9× | 0% | 350 in 2030−4.5%/yr |
| Cholecystectomy & appendectomy | 4 | 359−3.4%/yr | −3.4%/yr | 4.11.1× | 0% | 360 in 2030−0.1%/yr |
| Colorectal resection | 0 | 116−12%/yr | −12%/yr | 1.30.8× | 0% | 230 in 2030+12%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 9 | 436−3.7%/yr | −3.7%/yr | 4.90.9× | 0% | 440 in 2030+0.3%/yr |
| Hysterectomy, hysteroscopy & ablation | 6 | 346−0.6%/yr | −0.6%/yr | 4.21.3× | 0% | 430 in 2030+3.6%/yr |
| BPH procedures | 5 | 342+2.1%/yr | +2.1%/yr | 3.70.9× | 20% | 270 in 2030−3.7%/yr |
| Incontinence, prolapse & sacral neuromodulation | 2 | 201+0.4%/yr | +0.4%/yr | 2.21.2× | 31% | 130 in 2030−7.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 0 | 108−12%/yr | −12%/yr | 1.20.4× | 59% | 90 in 2030−3.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 25 | 1,437+8.2%/yr | +8.2%/yr | 17.12.1× | 37% | 1,840 in 2030+4.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 19 | 1,789+12%/yr | +12%/yr | 19.20.6× | 87% | 3,570 in 2030+12%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 9 | 460−6.3%/yr | −6.3%/yr | 5.31.1× | 0% | 500 in 2030+1.4%/yr |
| EP ablation | 8 | 382+4.9%/yr | +4.9%/yr | 3.41.0× | 0% | 920 in 2030+16%/yr |
| LAA occlusion & loop recorders | 5 | 246−0.3%/yr | −0.3%/yr | 2.30.7× | 0% | 350 in 2030+6.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 15 | 674−3.8%/yr | −3.8%/yr | 5.81.2× | 0% | 740 in 2030+1.6%/yr |
| Structural heart (TAVR, TEER) | 9 | 263+10%/yr | +10%/yr | 2.31.3× | 0% | 340 in 2030+4.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Stroke thrombectomy | 4 | 113+3.8%/yr | +3.8%/yr | 1.33.0× | 0% | 120 in 2030+1.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 27 | 7,5280%/yr | 0%/yr | 80.91.7× | 89% | 11,900 in 2030+7.9%/yr |
| Vitreoretinal surgery | 0 | 115−2.6%/yr | −2.6%/yr | 1.30.7× | 100% | 70 in 2030−8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 62 | 12,155−5.7%/yr | −5.7%/yr | 139.81.1× | 57% | 12,900 in 2030+1%/yr |
| ERCP & endoscopic ultrasound | 5 | 246−4.6%/yr | −4.6%/yr | 2.80.8× | 0% | 240 in 2030−0.5%/yr |
| Bronchoscopy & lung nodule | 4 | 147+4.9%/yr | +4.9%/yr | 1.60.6× | 0% | 310 in 2030+13%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.